XML 81 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
EQUITY METHOD INVESTMENTS (Tables)
12 Months Ended
Dec. 31, 2012
EQUITY METHOD INVESTMENTS [Abstract]  
Summarized financial information for CCE
The following table provides summarized financial information for CCE for the nine months ended October 1, 2010 (in millions):
 
Nine Months Ended

 
October 1, 2010

Net operating revenues
$
16,464

Cost of goods sold
10,028

Gross profit
$
6,436

Operating income (loss)
$
1,369

Net income (loss)
$
677

Summary of significant transactions with CCE
The following table provides a summary of our significant transactions with CCE for the nine months ended October 1, 2010 (in millions):
 
Nine Months Ended

 
October 1, 2010

Concentrate, syrup and finished product sales to CCE
$
4,737

Syrup and finished product purchases from CCE
263

CCE purchases of sweeteners through our Company
251

Marketing payments made by us directly to CCE
314

Marketing payments made to third parties on behalf of CCE
106

Local media and marketing program reimbursements from CCE
268

Payments made to CCE for dispensing equipment repair services
64

Other payments — net
19

Summarized financial information for equity method investees, excluding CCE
A summary of financial information for our equity method investees in the aggregate, other than CCE, is as follows (in millions):
Year Ended December 31,
2012

 
2011

 
2010

Net operating revenues
$
47,087

 
$
42,472

 
$
38,663

Cost of goods sold
28,821

 
26,271

 
23,053

Gross profit
$
18,266

 
$
16,201

 
$
15,610

Operating income
$
4,605

 
$
4,181

 
$
4,134

Consolidated net income
$
2,993

 
$
2,237

 
$
2,659

Less: Net income attributable to noncontrolling interests
89

 
99

 
89

Net income attributable to common shareowners
$
2,904

 
$
2,138

 
$
2,570

December 31,
2012

 
2011

Current assets
$
16,054

 
$
13,960

Noncurrent assets
32,687

 
27,152

Total assets
$
48,741

 
$
41,112

Current liabilities
$
12,004

 
$
10,545

Noncurrent liabilities
12,272

 
11,646

Total liabilities
$
24,276

 
$
22,191

Equity attributable to shareowners of investees
$
23,827

 
$
18,392

Equity attributable to noncontrolling interests
638

 
529

Total equity
$
24,465

 
$
18,921

Company equity investment
$
9,216

 
$
7,233